Listen Top Shows Blog

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Update: 2020-06-29

Share

Description

In this episode of The Pharma Podcast we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19.

My guest is Tiana DiMichele, Director, Business Development, Impres Inc.

Contact Information:
Tiana DiMichele, Director, Business Development
Phone: (416) 885-0023 |
E-mail: tianadimichele@imprespharma.ca

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Rare Voices: Navigating Life with Uncommon Courage in Canada

Rare Voices: Navigating Life with Uncommon Courage in Canada

2024-02-1731:36

Florida’s Prescription for Change: The Impact of Florida’s Move to Import Canadian Drugs!

Florida’s Prescription for Change: The Impact of Florida’s Move to Import Canadian Drugs!

2024-01-2429:45

A Year of Healing: Impact and Insights with Lois Brown from Health Partners International Canada

A Year of Healing: Impact and Insights with Lois Brown from Health Partners International Canada

2023-12-2027:45

Data Unleashed: Unmasking the Real World Evidence Revolution

Data Unleashed: Unmasking the Real World Evidence Revolution

2023-07-3151:06

Unlocking the Mind: Exploring Psilocybin's Potential for Healing PTSD and Enhancing Brain Health

Unlocking the Mind: Exploring Psilocybin's Potential for Healing PTSD and Enhancing Brain Health

2023-06-2626:44

Ukraine - Starting and Running a Business in Difficult Circumstances

Ukraine - Starting and Running a Business in Difficult Circumstances

2023-03-2820:04

Dr. Durhane Wong-Rieger - Bringing awareness to Rare Disease Day

Dr. Durhane Wong-Rieger - Bringing awareness to Rare Disease Day

2023-02-1548:12

The NEAR Future of Regenerative medicine

The NEAR Future of Regenerative medicine

2023-01-1327:17

CPOINT CAPITAL - How a Changing Economy is Affecting Investor Appetites

CPOINT CAPITAL - How a Changing Economy is Affecting Investor Appetites

2022-10-0818:04

Bloom Burton - Healthcare Investment Market in Canada

Bloom Burton - Healthcare Investment Market in Canada

2022-05-2436:34

Health Partners International of Canada's Emergency Response to UKRAINE

Health Partners International of Canada's Emergency Response to UKRAINE

2022-03-1319:36

Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?”

Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?”

2021-07-1625:52

Current Commercial Landscape for Pharma in Canada

Current Commercial Landscape for Pharma in Canada

2021-05-1711:37

Do BioSimilars Need a Patient Support Program?

Do BioSimilars Need a Patient Support Program?

2021-04-0513:27

CADTH - Streamlined Input Processes for Patients and Clinicians

CADTH - Streamlined Input Processes for Patients and Clinicians

2021-02-2722:22

PMPRB New Guidelines Affecting Drug Pricing in Canada

PMPRB New Guidelines Affecting Drug Pricing in Canada

2021-02-0217:35

Canadian Attitudes on Healthcare and Telemedicine

Canadian Attitudes on Healthcare and Telemedicine

2020-12-2128:52

Canadian R&D Investment & its Promise in the Wake of COVID-19

Canadian R&D Investment & its Promise in the Wake of COVID-19

2020-12-0122:23

COVID19 Vaccine Distribution in Canada-- Industry Perspective

COVID19 Vaccine Distribution in Canada-- Industry Perspective

2020-10-1921:17

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

2020-06-2919:32

00:00

00:00

1.0x

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19

Sam Tarantino